Nav: Home

New book gives comprehensive overview of astrocyte biology

July 27, 2016

RIVERSIDE, Calif. - Devin K. Binder, an associate professor of biomedical sciences in the School of Medicine at the University of California, Riverside, and Jacqueline A. Hubbard, a recent UC Riverside alumna, have coauthored a book, "Astrocytes and Epilepsy" (Academic Press, Elsevier, 2016), that provides a comprehensive overview of astrocyte biology, the role astrocytes play in epileptic brain tissue, and their potential as a therapeutic target.

Present throughout human history, epilepsy is a devastating group of neurological disorders characterized by periodic and unpredictable seizure activity in the brain. Periods of unusual behavior and sensations as well as loss of consciousness are also possible. Astrocytes - expansive star-shaped glial cells found in the brain - may represent an important new therapeutic target in the control of epilepsy. For the first time in book format, "Astrocytes and Epilepsy" reviews findings linking changes in astrocytes to functional changes responsible for epilepsy.

"The advances in research in astrocyte biology and astrocyte-neuron interactions over the past few years have identified entirely new ways to think about the development of seizures and epilepsy," Binder said. "In this book we review the changes that occur in astrocyte networks in epilepsy and propose novel therapeutic targets for the control of epilepsy with fewer side effects than conventional antiepileptic drug therapies. Discovery of the role of astrocytes in epilepsy is the most exciting recent research development in this field which makes this an especially good time to review this field in monograph format."

The book's intended audience is comprised of advanced graduate students, neuroscientists, epilepsy researchers, astrocyte investigators as well as neurologists and other specialists caring for patients with epilepsy.

Chapters include a history of astrocytes, astrocytes in the mammalian brain, types of epilepsy, neuropathology of human epilepsy, blood-brain barrier disruption, and inflammation. "Astrocytes and Epilepsy" is the first comprehensive book to synthesize historical and recent research on astrocytes and epilepsy into one coherent volume.

Binder attended Harvard University as an undergraduate, where he studied biology, anthropology, and neuroscience. Deciding to pursue both neuroscience and clinical medicine, he enrolled in the M.D./Ph.D. program at Duke University. At Duke, he graduated first in his medical school class. Subsequently, he completed a one-year internship in general surgery at UC San Francisco, and a six-year residency in neurological surgery at UCSF.

Following residency, he was awarded a one-year fellowship in neuroscience and neurosurgery at the University of Bonn. There, he did another fellowship at the Institute for Cellular Neuroscience. Following a three-year stint at UC Irvine, Binder joined UCR in 2010, where he runs the Translational Neuroscience Laboratory, and conducts research on astrocytes, epilepsy, and neurophotonics. A member of the Center for Glial-Neuronal Interactions on campus, he has been publishing in the epilepsy field since the 1990s, and has publications since 2004 relevant to astrocyte contribution to seizures and epilepsy.

As a graduate student, coauthor Hubbard worked closely with Binder on research focusing on characterizing astrocytic changes in epilepsy. She received her M.S. in biochemistry and molecular biology from UCR in 2012. She graduated with a Ph.D. in biochemistry and molecular biology this summer, and is pursuing a year of further postdoctoral study and training in Binder's laboratory.

"This book details why epilepsy is no longer considered simply a neuronal disease, but instead, is a complex group of disorders involving several different cell types and structures in the brain," Hubbard said. "It provides readers with a well-organized, comprehensive review of astrocyte biology, the myriad of epilepsy syndromes, and the functional roles that astrocytes play in the development and maintenance of epilepsy. We hope that readers will gain a complete understanding of the numerous changes currently known to occur in the epileptic brain."

Epilepsy affects about one percent of the US population. It can affect anyone at any stage in life. The causes of epilepsy and its treatments are varied. More about the disease can be found here.
-end-
The University of California, Riverside (http://www.ucr.edu) is a doctoral research university, a living laboratory for groundbreaking exploration of issues critical to Inland Southern California, the state and communities around the world. Reflecting California's diverse culture, UCR's enrollment has exceeded 21,000 students. The campus opened a medical school in 2013 and has reached the heart of the Coachella Valley by way of the UCR Palm Desert Center. The campus has an annual statewide economic impact of more than $1 billion. A broadcast studio with fiber cable to the AT&T Hollywood hub is available for live or taped interviews. UCR also has ISDN for radio interviews. To learn more, call (951) UCR-NEWS.

University of California - Riverside

Related Epilepsy Articles:

Breaching the brain's defense causes epilepsy
Epileptic seizures can happen to anyone. But how do they occur and what initiates such a rapid response?
Using connectomics to understand epilepsy
Abnormalities in structural brain networks and how brain regions communicate may underlie a variety of disorders, including epilepsy, which is one focus of a two-part Special Issue on the Brain Connectome in Brain Connectivity, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Epilepsy: Triangular relationship in the brain
When an epileptic seizure occurs in the brain, the nerve cells lose their usual pattern and fire in a very fast rhythm.
How concussions may lead to epilepsy
Researchers have identified a cellular response to repeated concussions that may contribute to seizures in mice like those observed following traumatic brain injury in humans.
Understanding epilepsy in pediatric tumors
A KAIST research team led by Professor Jeong Ho Lee of the Graduate School of Medical Science and Engineering has recently identified a neuronal BRAF somatic mutation that causes intrinsic epileptogenicity in pediatric brain tumors.
Can medical marijuana help treat intractable epilepsy?
A new British Journal of Clinical Pharmacology review examines the potential of medicinal cannabis -- or medical marijuana -- for helping patients with intractable epilepsy, in which seizures fail to come under control with standard anticonvulsant treatment.
Fertility rates no different for women with epilepsy
'Myth-busting' study among women with no history of infertility finds that those with epilepsy are just as likely to become pregnant as those without.
Do women with epilepsy have similar likelihood of pregnancy?
Women with epilepsy without a history of infertility or related disorders who wanted to become pregnant were about as likely as their peers without epilepsy to become pregnant.
Hope for new treatment of severe epilepsy
Researchers at Lund University in Sweden believe they have found a method that in the future could help people suffering from epilepsy so severe that all current treatment is ineffective.
Many epilepsy patients take drug combinations that interact
In an Epilepsia analysis of 2008-2010 Medicare claims data, one in four older Americans with new-onset epilepsy and more than one-third with prevalent epilepsy received a combination of antiepileptic drugs and non-epilepsy drugs that could interact to alter the effectiveness of the non-epilepsy drugs.
More Epilepsy News and Epilepsy Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

In & Out Of Love
We think of love as a mysterious, unknowable force. Something that happens to us. But what if we could control it? This hour, TED speakers on whether we can decide to fall in — and out of — love. Guests include writer Mandy Len Catron, biological anthropologist Helen Fisher, musician Dessa, One Love CEO Katie Hood, and psychologist Guy Winch.
Now Playing: Science for the People

#542 Climate Doomsday
Have you heard? Climate change. We did it. And it's bad. It's going to be worse. We are already suffering the effects of it in many ways. How should we TALK about the dangers we are facing, though? Should we get people good and scared? Or give them hope? Or both? Host Bethany Brookshire talks with David Wallace-Wells and Sheril Kirschenbaum to find out. This episode is hosted by Bethany Brookshire, science writer from Science News. Related links: Why Climate Disasters Might Not Boost Public Engagement on Climate Change on The New York Times by Andrew Revkin The other kind...
Now Playing: Radiolab

An Announcement from Radiolab